Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OverTTuRe: An Observational Multi-Country Study Collecting Real-World Secondary Data on the Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis

NCT06355934 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06355934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06355934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OverTTuRe: An Observational Multi-Country Study Collecting Real-World Secondary Data on the Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
August 21, 2023
Completion date
November 2, 2026
Enrollment
52,121 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

attr amyloidosis